Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 1, 2020Cell ReportsOpen Access

Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice

View Full Paper
Ask AI
Bookmark
Share

Authors

APAndrea J. PruijssersVanderbilt HealthAGAmelia S. GeorgeVanderbilt University Medical CenterASAlexandra SchäferUniversity of North Carolina at Chapel Hill

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Pruijssers et al. (2020) studied this question.

synapsesocial.com/papers/6a791aa89fd4195bcd5af2aehttps://doi.org/10.1016/j.celrep.2020.107940
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cell-line dependent antiviral activity of sofosbuvir against Zika virus2017 · 92 citations
  2. 2Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV2020 · 1,816 citations
  3. 3Compassionate Use of Remdesivir for Patients with Severe Covid-192020 · 2,909 citations
  4. 4Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors2019 · 958 citations
  5. 5Well-Differentiated Human Airway Epithelial Cell Cultures2004 · 637 citations